LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of vasopressin receptor antagonist for regulation of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of VEGF and homologues to treat neuron disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...

Use of vital dye for facilitating surgical procedures for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of vitamin B6 to mitigate visual field defects...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of vitamin C or derivatives or analogues thereof promoting s

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of vitamin combination for the treatment of pruritus and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Use of vitamin D analogs to treat conditions related to...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Use of vitamin D compounds to prevent transplant rejection

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Use of vitamin D-derivatives in the treatment of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of vitamin E tocopheryl derivatives in ophthalmic compositio

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Use of vitamin-D analogues in the treatment of acne

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of VWF-containing concentrates as a therapy which is employe

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of water-soluble β-(1,3) glucans as agents for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of weak opioids and mixed opioid agonists/antagonists...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of xanthine derivatives for the inhibition of dephosphorylat

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of xanthine derivatives for the modulation of apoptosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of xanthine oxidase inhibitors as anti-ischaemic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of xanthines as immunosuppressants and to inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai

Use of xylitol and pharmaceutical compositions therefor